Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Check your cabinets: More than 140,000 bottles of cholesterol medication part of elevated recall over health risk

The tablets were distributed nationwide in up to 1,000-count bottles

The Independent UK

Biogen's Immunology Pipeline Has Long-Term Potential: Analyst

On Friday, Biogen Inc. (NASDAQ:BIIB) and Vanqua Bio announced a license agreement granting Biogen exclusive worldwide rights to Vanqua's preclinical, oral C5aR1 antagonist. The agreement strengthens Biogen's immunology.

Benzinga

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark

Sanofi SA (NASDAQ:SNY) reported third-quarter sales of $14.55 billion (12.43 billion euros), beating the consensus of $14.46 billion. Sales increased 2.3% year over year, up 7% in constant currency.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep

On Friday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy.

Benzinga

7 FDA Approvals That Should Never Have Happened

Every time you see the words “FDA approved,” it’s supposed to mean safety, science, and trust. After all, the Food and Drug Administration is the final checkpoint before a product reaches your medicine cabinet, right? But history says otherwise. Over the years, some truly shocking—and sometimes disastrous—products have slipped through…

Everybody Loves Your Money

Neutrogena Issues Recall of Makeup Wipes That Tested Positive for Harmful Bacteria

Neutrogena recalls makeup wipes after tests found harmful bacteria, urging consumers to stop use immediately.

International Business Times

Intel, Scienture Holdings, Ford, Deckers, And Super Micro Computer: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average up 0.3% at 46,734.61, the SP 500 advancing nearly 0.6% to 6,738.44, and the Nasdaq climbing about 0.9% to 22,941.79.These are the top stocks that gained the attention of retail traders and investors through the day: Intel…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

9 OTC Cold Remedies That Don’t Work as Advertised

When you have a cold, you will do almost anything to feel better fast. The pharmacy aisle is filled with over-the-counter (OTC) remedies that promise quick relief from your symptoms. However, many of these popular products make claims that are not supported by strong scientific evidence. While they may offer…

Grocery Coupon Guide

Three Coke products all under recall for ‘foreign material’ inside the cans

Coca-Cola and the FDA say they have not received any reports of consumers being injured by the recalled Coke and Sprite cans

The Independent UK

More shrimp recalled over possible radioactive contamination. See the full list of stores and states

Some of the shrimp have been sold at Publix stores in eight states

The Independent UK

Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.

The former consumer health unit of Johnson & Johnson remains mired in troubles surrounding Tylenol.

Barchart

Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz

On Wednesday, Alkermes plc (NASDAQ:ALKS) agreed to acquire Avadel Pharmaceuticals plc (NASDAQ:AVDL) for up to $20 per share in cash, which values Avadel at approximately $2.1 billion.

Benzinga

Trump’s approach to lowering drug costs is raising questions - Roll Call

Several drug pricing experts say without key details, it’s hard to call the individual pharma deals a win for the Trump administration.

Roll Call

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial

Minerva Neurosciences Inc (NASDAQ:NERV) shares are climbing Tuesday after the company announced up to $200 million in funding to support development of roluperidone for schizophrenia.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Gen Zers are turning to frozen food to stretch their budgets and they don’t feel good about it

Somehow, the generation most skeptical about frozen food’s nutrition, quality, and safety is the one that's most been forced into its frosty arms.

The Mary Sue

‘I’m sifting everything from now on’: California woman starts making Betty Crocker brownies. Then she sees something moving

A California woman’s baking session turned from sweet to sickening when she discovered something alive in her brownie mix. Safe to say, she probably didn’t end up finishing the baking process.

Android Central

Stay ahead of your health, as Oura brings new tools for stress and blood pressure

Oura announced updates for its Preventive Health features and UI.

Benzinga

Here's Why Replimune Group (REPL) Stock Is Up Over 100% Today

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update.

Get all your
news in one place.

100's of premium titles.
One news app.

Grocery Coupon Guide

6 OTC Painkillers That Are Exactly the Same Formula

When you shop for over-the-counter (OTC) painkillers, it’s easy to get overwhelmed by the number of brands and labels. Many people assume that different names mean different formulas. The truth is, several leading OTC painkillers are exactly the same formula, just packaged with different branding and prices. Understanding which painkillers…

The Mary Sue

‘I never noticed a difference’: Indiana woman buys can of Monster. Then she buys the same can—but it has a green tab

A TikTok content creator is warning her audience to be “careful” after consuming a few Monster energy drinks she posits are counterfeit. In a video with over 27,000 views, @thriftybuzinezz explained how she noticed a difference between cans with green and metallic-colored tabs.

International Business Times UK

Pfizer Birth Control Scandal: 1,000 Women Sue Over Brain Tumour Risk After Using Popular Contraceptive

Pfizer faces lawsuits from 1,000 women alleging Depo-Provera birth control caused brain tumours, amid new research showing higher meningioma risk.

The Independent UK

Egg recall upgraded to FDA’s highest alert level indicating ‘reasonable probability’ of serious illness

The cases of eggs were recalled in September

Benzinga

Kezar Launches Strategic Review As FDA Roadblock Derails Liver Drug Plans

Kezar Life Sciences, Inc. (NASDAQ:KZR) announced regulatory updates and began exploring strategic alternatives.

Benzinga

Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Friday.

Benzinga

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Friday.

1 … 38 39 40 41

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.